Open report — full analysis, no account required.
Sign up to generate reports and read filings that aren't on the open list.
Get notified when NEO files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsNeoGenomics prices convertible senior notes offering due 2032
Filed June 17, 2026 · Period ending June 17, 2026 · ~1 min read
Key Changes
-
high
Company priced an offering of convertible senior notes maturing in 2032, sold to institutional buyers under Rule 144A private placement rules. Specific terms including size, conversion price, and use of proceeds not disclosed in the 8-K filing itself.
Item 8.01 verify on EDGAR →
Summary
NeoGenomics announced it has priced a convertible senior notes offering due 2032, targeting qualified institutional buyers through a private placement. Convertible notes are debt instruments that can be converted into company stock under certain conditions, typically used to raise capital at lower interest rates than traditional debt while potentially diluting existing shareholders if converted. The 8-K filing itself does not disclose critical details such as the offering size, conversion price, interest rate, or intended use of proceeds—those specifics would be in the accompanying press release.
For retail investors, this matters because convertible debt increases the company's leverage and creates potential future dilution. Watch for the full terms in subsequent filings or press releases, particularly the conversion premium and whether proceeds will fund operations, acquisitions, or debt refinancing.
Section-by-Section Diff
Event · Item 8.01 — Other Events
Item 8.01 — Other Events filed; see Key Changes for terms.
Added in current filing · verify on EDGAR →
On June 17, 2026, NeoGenomics, Inc. (the “Company”) issued a press release relating to the pricing of its offering of convertible senior notes due 2032 to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Convertible Notes Offering”).
The company announced the pricing of a convertible senior notes offering maturing in 2032. These notes are being sold to qualified institutional buyers under Rule 144A, which is a private placement exemption. The 8-K does not disclose the size, pricing terms, conversion rate, or use of proceeds — those details would be in the referenced press release exhibit.
Thanks — your feedback helps us improve report quality.
Figures/quotes linked to EDGAR · Narrative written by AI · Jun 17, 2026 · How we verify